Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 8, 2024
Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors?
Gavitt A Woodard, Sanja Dacic
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling
Gavitt A Woodard, David M Jablons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2025
Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?
Gavitt A Woodard, Brendon M Stiles
Translational Lung Cancer Research
|
March 25, 2020
Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
Gavitt A Woodard, David M Jablons
The Journal of Thoracic and Cardiovascular Surgery
|
October 13, 2025
Commentary: Will TROPION be a CHAMPION in stage I lung cancer?
Gavitt A Woodard, Brendon M Stiles
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 7, 2024
Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs?
Gavitt A Woodard, David M Jablons
The New England Journal of Medicine
|
November 29, 2018
Cast of the Right Bronchial Tree
Gavitt A Woodard, Georg M Wieselthaler
Annals of Surgical Oncology
|
October 30, 2023
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Gavitt A Woodard, Christina Cho, Lieping Chen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 25, 2022
Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response?
Gavitt A Woodard, Christina Cho, Lieping Chen
The Journal of Thoracic and Cardiovascular Surgery
|
August 2, 2021
Role of adjuvant therapy in T1-2N0 resected non-small cell lung cancer
Gavitt A Woodard, Andrew Li, Daniel J Boffa
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 8, 2024
Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors?
Gavitt A Woodard, Sanja Dacic
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 21, 2015
The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling
Gavitt A Woodard, David M Jablons
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2025
Is Major Pathologic Response the Best Surrogate End Point for Neoadjuvant Trials?
Gavitt A Woodard, Brendon M Stiles
Translational Lung Cancer Research
|
March 25, 2020
Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma
Gavitt A Woodard, David M Jablons
The Journal of Thoracic and Cardiovascular Surgery
|
October 13, 2025
Commentary: Will TROPION be a CHAMPION in stage I lung cancer?
Gavitt A Woodard, Brendon M Stiles
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 7, 2024
Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs?
Gavitt A Woodard, David M Jablons
The New England Journal of Medicine
|
November 29, 2018
Cast of the Right Bronchial Tree
Gavitt A Woodard, Georg M Wieselthaler
Annals of Surgical Oncology
|
October 30, 2023
Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis?
Gavitt A Woodard, Christina Cho, Lieping Chen
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 25, 2022
Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response?
Gavitt A Woodard, Christina Cho, Lieping Chen
The Journal of Thoracic and Cardiovascular Surgery
|
August 2, 2021
Role of adjuvant therapy in T1-2N0 resected non-small cell lung cancer
Gavitt A Woodard, Andrew Li, Daniel J Boffa
Page
of 7